Brio Blogs

Manufacturers of Sterilants and Disinfectants Report on Latest Trends

Briotech breakthrough in the inactivation of prion infectivity highlighted for medical instrument sterilization.

Healthcare Purchasing News
November 16, 2016

Chemical Warfare for Instruments
"It seems like every few months another story on "dirty" surgical instruments hits the media and causes shockwaves throughout the industry. These news reports call attention to what those in the central sterile/sterile processing department (CS/SPD) have long known — that their jobs are critical to delivering safe and effective patient care.

Proteinaceous infectious particles, commonly known as "prions" are pathogens that are composed of ‘unfolded’ proteins containing no DNA. Creutzfeldt-Jakob disease (CJD) and even evidence that suggests Alzheimer’s disease are examples of transmissible spongiform encephalopathies (TSE) which progress rapidly in the brain and are always fatal making them a major concern to healthcare professionals.

"The reprocessing of contaminated instruments that may have been exposed to CJD/TSE in healthcare facilities today need to be assessed. Due to the resilience of prions and potential of the unknown possibility that a patient may have CJD, instrument reprocessing becomes more challenging."

Investigators at the U.S. National Institute of Allergy and Infectious Diseases (NIAID) Rocky Mountain Laboratories, in collaboration with researchers at the University of Washington (UW) Bothell, UW Seattle and the University of Verona (Italy), recently demonstrated the effectiveness of Briotech’s patent- pending unique proprietary formula hypochlorous acid (HOCl) in inactivating prions. HOCl is naturally produced in the body’s cells to aid in ridding it of microbes. Washington-based Briotech has developed BrioHOCl™, a proprietary disinfectant comprised of HOCl, for use in consumer and professional healthcare settings."

Full Article

Empty content. Please select category to preview